Sirrs, S M <br/><br/>
Outcomes of patients treated through the Canadian Fabry disease initiative.  [electronic resource] 

 -  Molecular genetics and metabolism  Apr 2014 
 - 499-506 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-7206 
<br/><br/><label>Standard No.: </label>10.1016/j.ymgme.2014.01.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Canada<br/>Cardiovascular Diseases--etiology<br/>Cohort Studies<br/>Endpoint Determination<br/>Enzyme Replacement Therapy<br/>Fabry Disease--complications<br/>Female<br/>Humans<br/>Isoenzymes--therapeutic use<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Recombinant Proteins<br/>Risk Factors<br/>Treatment Outcome<br/>alpha-Galactosidase--therapeutic use